Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY
Document Type and Number:
WIPO Patent Application WO/2015/150324
Kind Code:
A1
Abstract:
The present invention relates to organic light emitting elements, comprising thermally activated delayed fluorescence (TADF) emitters and/or hosts on basis of benzotriazoles, which have a sufficiently small energy gap between S1 and T1 (ΔEST) to enable up-conversion of the triplet exciton from T1 to S1. The organic light emitting elements show high electroluminescent efficiency.

Inventors:
TANABE JUNICHI (JP)
LENNARTZ CHRISTIAN (DE)
Application Number:
PCT/EP2015/056892
Publication Date:
October 08, 2015
Filing Date:
March 30, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BASF SE (DE)
International Classes:
C09K11/06; C07D249/20; H01L51/00; H01L51/50; H05B33/14
Domestic Patent References:
WO2005054212A22005-06-16
WO2003105538A12003-12-18
WO2005054212A22005-06-16
WO2013054764A12013-04-18
Foreign References:
EP2265092A12010-12-22
EP2128216A12009-12-02
EP0418386A11991-03-27
US4533612A1985-08-06
EP1786050A12007-05-16
EP1970371A12008-09-17
EP1097981A22001-05-09
Other References:
MUSUBU ICHIKAWA ET AL: "Bipyridyl-substituted benzo[1,2,3]triazoles as a thermally stable electron transporting material for organic light-emitting devices", JOURNAL OF MATERIALS CHEMISTRY, vol. 21, no. 32, 4 July 2011 (2011-07-04), pages 11791, XP055130667, ISSN: 0959-9428, DOI: 10.1039/c1jm10901d
C. ADACHI ET AL., ADV. MATER., vol. 21, 2009, pages 4802
APPL. PHYS. LETT., vol. 98, 2011, pages 083302
CHEM. COMMUN., vol. 48, 2012, pages 9580
MUSUBU ICHIKAWA ET AL., J. MATER. CHEM., vol. 21, 2011, pages 11791 - 11799
ADV. MATER., vol. 20, 2008, pages 3325 - 3330
Attorney, Agent or Firm:
LEYBACH, Holger (- IP Department -P.O. Box, Basel, CH)
Download PDF:
Claims:
Claims

An organic light-emitting element, comprising a light-emitting layer comprising

i) a compound of formula (I) as guest and a host material; or

ii) a compound of formula (I) as host and a fluorescent guest material, wherein

R1 , R2, R3 and R4 are independently of each other H, D, F, CI, a Ci-C2salkyl group, a

R5, Re, RJ, R8 and R9 are independenlly of each other H, D, F, CI, a Ci-C25alkyl group, a Ci-C25alkoxy group, a C6-Cioaryloxy group, a group of formula

, (Xa), (Xb), (Xc), or (Xd);

R1 ', R2', R3' and R4' are independently of each other H, D, F, CI, a Ci-C2salkyl group, a Ci-C25alkoxy group, or a C6-Cioaryloxy group; or R1 and R2 together form a group of formula

R1' and R2' together form a group of formula

R3 and R4 together form a group of formula

R3' and R4' together form a group of formula

R5 and R6 together form a group of formula ; and/or

R8 and R9 together form a group of formula ;

A1, A2, A3, A4, A5, A6, A7 and A8 are independently of each other H, D, F, CI, a Ci-

C25alkyl group, or a donor group of formula (Xa), (Xb), (Xc), or (Xd);

A9, A10, A11, A12, A13, A14, A15 and A16 are independently of each other H, D, F, CI, a

Ci-C25alkyl group, or a donor group of formula (Xa), (Xb), (Xc), or (Xd);

X1 and X2 are independently of each other a single bond, O, S, N(R15), C(=0),

C(R 6)(R17), B(Ris), or Si(R 9)(R20) and

R10, R11, R12, R13, R21 and R2 ' are independently of each other H, D, F, CI, or a Ci- C25alkyl group;

R14, R15, R16, R17, R18, R19 and R20 are independently of each other H, D, a Ci- C25alkyl group, or a C6-Ci4aryl group, which can optionally be subituted by one, or more groups selected from a Ci-C2salkyl group, a Ci-C2salkoxy group and a C6- C-ioaryloxy group;

with the proviso that at least one donor group of formula (Xa), (Xb), (Xc), or (Xd) is present in the compound of formula (I); characterized in that it emits delayed fluorescence. The organic light-emitting element according to claim 1 , wherein

R1 , R2, R3, R R8 anc| R9 are independently of each other H, a Ci-C25alkyl g mula

and R2 together form a group of formula ; and/or

R8 and R9 together form a group of formula

R5 is H, a Ci-C25alkyl group, a group of formula , or a donor group of formula (Xa), (Xb), (Xc), or (Xd);

X1 and X2 are independently of each other a single bond, O, S, C(O), N(R15), or C(R 6)(R17); and

R10, R11, R12, R13, R21 and R2 ' are independently of each other H, or a Ci-C25alkyl group;

R ently of each other a group of formula , or

R16 and R17 are independently of each other H, a Ci-C2salkyl group;

R22 and R23 are independently of each other H, a Ci-C2salkyl group, a Ci-C2salkoxy group, or a C6-Cioaryloxy group; with the proviso that at least one of R , R2, R3, R4, R5, R6, R7, R8 and R9 is a donor group of formula (Xa), (Xb), (Xc), or (Xd).

The organic light-emitting element according to claim 1 , or 2, wherein the compound of formula (I) is a compound of formula

(la), wherein

R and R2 are independently of each other H, or a Ci-C25alkyl group, or

R and R2 together form a group of formula

, or a donor

r a donor group of formula (Xa), (Xb), (Xc), or (Xd);

R9 is H, or

R8 and R9 together form a group of formula

X1 and X2 are independently of each other a single bond, O, S, N(R15), or

C(R 6)(R17);

Rio, R11, Ri2, R13, R2i and R21' are independently of each other H, or a Ci-C25alkyl group; R ently of each other a group of formula or

R16 and R17 are independently of each other H, a Ci-C25alkyl group;

R22 and R23 are independently of each other H, or a Ci-C25alkyl group;

with the proviso that at least one of R3, R5 and R7 is a donor group of formula (Xa),

(Xb), (Xc), or (Xd).

The organic light-emitting element according to claim 3, wherein the compound of

. 1

R

formula (I) is a compound of formula da'), wherein

R1 and R2 are independently of each other H, or a Ci-C2salkyl group, or

R1 and R2 together form a group of formula

R3 is H, a Ci-C25alkyl group, or a donor group of formula (Xa),

R7 is H, a Ci-C25alkyl group, or a donor group of formula (Xa), (Xb), (Xc), or (Xd); R8 and R9 are H, or

R8 and R9 together form a group of formula χι and X2 are independently of each other a single bond, O, S, N(Ris), or C(R 6)(R17); R10, Rii, R12, R13, R21 and 2 are independently of each other H, or a Ci-C25alkyl group;

R ently of each other a group of formula or

R16 and R17 are independently of each other H, a Ci-C25alkyl group;

R22 and R23 are independently of each other H, or a Ci-C25alkyl group;

with the proviso that at least one of R3 and R7 is a donor group of formula (Xa), (Xb),

(Xc), or (Xd).

The organic light-emitting element according to claim 3, wherein the compound of formula (I) is a compound of formula

"), wherein

R3 and R5 are H and R7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or R3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R5 and R7 are H; or R5 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R3 and R7 are H; or R3 and R7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R5 is H; or (la'"), wherein

R3 and R5 are H and R7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or R3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R5 and R7 are H ; or R5 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R3 and R7 are H ; or R3 and R7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R5 is H ; and X1 and X2 are independently of each other a single bond, O, S, N(R15), or C(R16)(R17); R8 and R9 are H, or

R8 and R9 together form a group of formula ;

R10, R11, R12, R13, R21 and R2 ' are independently of each other H, or a Ci-C25alkyl group;

R ently of each other a group of formula , or

R16 and R17 are independently of each other H, a Ci-C25alkyl group;

R22 and R23 are independently of each other H, or a Ci-C2salkyl group.

The organic light-emitting element according to claim 5, wherein the compound of formula (I) is a compound of formula (la"), wherein

is H and R7 is a donor group of formula (Xa),

or

R3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R7 is H;

R3 and R7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la"), wherein

R5 is H;

R8 and R9 together form a group of formula

R3 is H and R7 is a donor group of formula (Xa),

(Xb), (Xc), or (Xd); or

R3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R7 is H; or

R3 and R7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la"), wherein

R3, R7 , R8 and R9 are H;

R5 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la'"), wherein

R3 is H and R7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

R3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R7 is H; or

R3 and R7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la'"), wherein

R5 is H;

R8 and R9 together form a group of formula ;

R3 is H and R7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

R3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R7 is H; or

R3 and R7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la'"), wherein

R3, R7 , R8 and R9 are H;

R5 is a donor group of formula (Xa), (Xb), (Xc), or (Xd);

X1 and X2 are independently of each other a single bond, O, S, N(R15), or C(R16)(R17); R10, R11, R12, R13, R21 and R2 ' are independently of each other H, or a Ci-C25alkyl group;

R 15 are independently of each other a group of formula , or

R16 and R17 are independently of each other H, a Ci-C25alkyl group;

R22 and R23 are independently of each other H, or a Ci-C2salkyl group.

The organic light-emitting element according to claim 3, wherein the compound of

or

a compound of formula (lb), wherein

R5 is a donor group of formula (Xa), (Xb), (Xc), or (Xd), and

R7 and R8 are are independently of each other H, or a Ci-C2salkyl group; and

Xi and X2 are independently of each other a single bond, O, S, N(R15), or C(R 6)(R17);

Ri°, R11, R12, R13, R21 and R21' are independently of each other H, or a Ci-C25alkyl group; R ently of each other a group of formula or

R16 and R17 are independently of each other H, a Ci-C2salkyl group;

R22 and R23 are independently of each other H, or a Ci-C25alkyl group.

The organic light-emitting element according to claim 1 , wherein the compound of formula (I) is a compound of formula

(lc), wherein

. 1

R1 and R4 are a donor group of formula (Xa),

and

Xi and X2 are independently of each other a single bond, O, S, N(Ris), or C(R 6)(R17); R8 and R9 are H, or

R8 and R9 together form a group of formula

Ri°, Rii, Ri2, R 3, R21 and R21' are independently of each other H, or a Ci-C25alkyl group; R ently of each other a group of formula , or

R16 and R17 are independently of each other H, a Ci-C25alkyl group;

R22 and R23 are independently of each other H, or a Ci-C25alkyl group.

The organic light-emitting element according to any of claims 1 to 8, wherein the donor group is a donor la (Xa), wherein X1 is a single bond, O, S,

C(CH3)(CH3), C(=0), ; or a donor group of formula (Xb), wherein X2 is a or a donor group of formula (Xc), wherein R13 is a group of

and R14 is a group of formula or

donor group of formula (Xd), wherein R21 and R21 ' are H. 10. The organic light-emitting element according to any of claims 1 to 9, wherein the do-

n

11. A compound of formula (I), wherein

R1, R2, R3 and R4 are independently of each other H, D, F, CI, a Ci-C25alkyl group, a C group of formula

R5, Re, R7, R8 and R9 are independenlly of each other H, D, F, CI, a Ci-C25alkyl group, a Ci-C25alkoxy group, a C6-Cioaryloxy group, a group of formula

R1', R2', R3' and R4' are independently of each other H, D, F, CI, a Ci-C2salkyl group, a Ci-C25alkoxy group, or a C6-Cioaryloxy group;

R1 and R2 together form a group of formula

R1' and R2' together form a group of formula R3 and R4 together form a group of formula

R3' and R4' together form a group of formula

R5 and R6 together form a group of formula ; and/or

R8 and R9 together form a group of formula ;

A1, A2, A3, A4, A5, A6, A7 and A8 are independently of each other H, D, F, CI, a Ci-

C25alkyl group, or a donor group of formula (Xa), (Xb), or (Xd);

A9, A10, A11, A12, A13, A14, A15 and A16 are independently of each other H, D, F, CI, a

Ci-C25alkyl group, or a donor group of formula (Xa), (Xb), or (Xd);

Xi and X2 are independently of each other O, S, N(Ris), C(R 6)(R17), B(Ri8), or

Si(R 9)(R20) and

R10, R11, R12, R21 and R2 ' are independently of each other H, D, F, CI, or a Ci- C25alkyl group;

R15, R16, R17, R18, R19 and R20 are independently of each other H, a Ci-C25alkyl group, or a C6-Ci4aryl group;

with the proviso that at least one donor group of formula (Xa), (Xb), or (Xd) is present in the compound of formula (I).

12. The compound according to claim 11 , wherein

R1, R2, R3, R4, Re, R7, R8 and R9 are independently of each other H, a Ci-C25alkyl group, a Ci-C2salkoxy group, a C6-Cioaryloxy group, a donor group of formula

and R2 together form a group of formula ; and/or

R8 and R9 together form a group of formula

R5 is H, a Ci-C25alkyl group, a group of formula , or a donor group of formula (Xa), (Xb), or (Xd);

Xi and X2 are independently of each other O, S, N(R15), or C(R 6)(R17); and

Rio Rii R12 R21 anc| R21 ' are inde endentl of each other H, or a Ci-C25alkyl group;

R15 is a group of formula , or

R16 and R17 are independently of each other H, a Ci-C2salkyl group;

R22 and R23 are independently of each other H, a Ci-C2salkyl group, a Ci-C2salkoxy group, or a C6-Cioaryloxy group;

with the proviso that at least one of R , R2, R3, R4, R5, R6, R7, R8 and R9 is a donor group of formula (Xa), (Xb), or (Xd).

The compound according to claim 11 , or 12, wherein the compound of formula (I) is

(la), wherein R1 and R2 are independently of each other H, or a Ci-C25alkyl group, or

R1 and R2 together form a group of formula

R3, R7 and R8 are independently of each other H, a Ci-C2salkyl group, or a donor

group of formula (Xa), (Xb), or

R5 is H, a Ci-C25alkyl group, a group of formula , or a donor group of formula (Xa), (Xb), or (Xd);

R9 is H, or

R8 and R9 together form a group of formula

Xi and X2 are independently of each other O, S, N(Ris), or C(R 6)(R17);

Rio RI I _ R12 R21 anc| R21 ' C25alkyl group;

R15 is a group of formula , or

R16 and R17 are independently of each other H, a Ci-C2salkyl group;

R22 and R23 are independently of each other H, or a Ci-C2salkyl group;

with the proviso that at least one of R3, R5 and R7 is a donor group of formula (Xa), (Xb), or (Xd). The compound according to claim 13, which is a compound of formula

(la'), wherein

R1 and R2 are independently of each other H, or a Ci-C25alkyl group, or

R1 and R2 together form a group of formula

(Xa),

R7 is H, a Ci-C25alkyl group, or a donor group of formula (Xa), (Xb), or (Xd);

R8 and R9 are H, or

R8 and R9 together form a group of formula

Xi and X2 are independently of each other O, S, N(Ris), or C(R16)(R17);

Rio Rii R12 R21 anc| R21' are independently of each other H, or a Ci-C25alkyl group;

R15 is a a group of formula , or

R16 and R17 are independently of each other H, a Ci-C2salkyl group;

R22 and R23 are independently of each other H, or a Ci-C2salkyl group;

with the proviso that at least one of R3 and R7 is a donor group of formula (Xa), (Xb), or (Xd).

15. The compound according to claim 13, which is a compound of formula

(la"), wherein

R3 and R5are H and R7 is a donor group of formula (Xa),

R3 is a donor group of formula (Xa), (Xb), or (Xd) and R5and R7are H; or

R5 is a donor group of formula (Xa), (Xb), or (Xd) and R3and R7are H; or

ula (Xa), (Xb), or (Xd) and R5is H; or

(la'"), wherein

R3 and R5are H and R7 is a donor group of formula (Xa), (Xb), or (Xd); or

R3 is a donor group of formula (Xa), (Xb), or (Xd) and R5and R7are H; or

R5 is a donor group of formula (Xa), (Xb), or (Xd) and R3and R7are H; or

R3 and R7are a donor group of formula (Xa), (Xb), or (Xd) and R5is H; and

Xi and X2 are independently of each other O, S, N(Ris), or C(R6)(R17);

R8 and R9 are H, or

R8 and R9 together form a

R10, R11, R12, R21 and R21' C25alkyl group;

R15 is a group of formula , or

R16 and R17 are independently of each other H, a Ci-C25alkyl group;

R22 and R23 are independently of each other H, or a Ci-C2salkyl group.

16. The compound according to claim 15, wherein the compound of formula (I) is a compound of formula (la"), wherein

R3 is H and R7 is a donor group of formula (Xa),

R3 is a donor group of formula (Xa), (Xb), or (Xd) and R7 is H; or

R3 and R7 are a donor group of formula (Xa), (Xb), or (Xd); or

a compound of formula (la'"), wherein

R3 is H and R7 is a donor group of formula (Xa), (Xb), or (Xd); or

R3 is a donor group of formula (Xa), (Xb), or (Xd) and R7 is H; or

R3 and R7 are a donor group of formula (Xa), (Xb), or (Xd) and

Xi and X2 are independently of each other O, S, N(Ris), or C(R 6)(R17);

R10, R11, R12, R21 and R21 ' C25alkyl group;

R15 is a group of formula , or

R16 and R17 are independently of each other H, or a Ci-C25alkyl group;

R22 and R23 are independently of each other H, or a Ci-C2salkyl group.

The compound according to claim 13, wherein the compound of formula (I)

group of formula

R7 and R8 are a donor group of formula (Xa),

a compound of formula (lb), wherein

R5 is a donor group of formula (Xa), (Xb), or (Xd), and

R7 and R8 are are independently of each other H, or a Ci-C25alkyl group; and Xi and X2 are independently of each other O, S, N(Ris), or C(R 6)(R17);

Rio I I _ R12 R21 anc| R21' C25alkyl group;

R15 is a group of formula , or

R 6 and R17 are independently of each other H, a Ci-C2salkyl group;

R22 and R23 are independently of each other H, or a Ci-C2salkyl group.

18. The compound according to claim 11 , wherein the compound of formula (I) is a com

(lc), wherein

R and R4 are a donor group of formula (Xa),

Xi and X2 are independently of each other O, S, N(Ris), or C(R 6)(R17);

R8 and R9 are H, or

R8 and R9 together form a

R10, R11, R12, R21 and R21 ' C25alkyl group;

R15 is a group of formula , or

R16 and R17 are independently of each other H, a Ci-C25alkyl group;

R22 and R23 are independently of each other H, or a Ci-C2salkyl group. 19. The compound according to any of claims 10 to 18, wherein the donor group is a

donor group of formula (Xa), wherein X1 is O, S, C(CH3)(CH3), C(=0),

or a donor group of formula (Xb), wherein X2 is a single bond and R12 is H; or a donor group of formula (Xd), wherein R21 and R21 ' are H. 20.

A light-emitting layer comprising the compound according to any of claims 11 to 20.

22. An organic light emitting element, comprising the compound according to any of claims 11 to 20.

Use of the compounds of formula (I) according to any of claims 11 to 20 for electrophotographic photoreceptors, photoelectric converters, sensors, dye lasers, solar cell devices and organic light emitting elements.

24. Use of the compounds of formula (I) according to claim 1 , or 11 for generating delayed fluorescence emission.

Description:
Fluorescent Organic Light Emitting Elements Having High Efficiency

Description The present invention relates to organic light emitting elements, comprising thermally activated delayed fluorescence (TADF) emitters and/or hosts on basis of benzotriazoles, which have a sufficiently small energy gap between Si and Ti (AEST) to enable up-conversion of the triplet exciton from Ti to Si. The organic light emitting elements show high electroluminescent efficiency.

The development of OLED luminescent materials is an important issue and these materials have been classified into two major categories. The first is fluorescent materials, which can harvest only the singlet excitons (25%) that are generated by electrical excitation. The second is phosphorescent materials, which can harvest the triplet excitons generated (75%). The branching ratio of singlet and triplet excitons is 1 : 3. Therefore, in recent devices, phosphorescent materials and their related technologies have been indispensable to obtain high EL efficiency. However, phosphorescent materials generally contain a rare metal element such as Ir or Pt. These metals are rather expensive and are dependent on limited global resources.

Recently, the alternative concept of thermally activated delayed fluorescence (TADF) as a third generation luminescent material, instead of the conventional fluorescent and phosphorescent materials was decribed by C. Adachi et al. in Adv. Mater., 2009, 21 , 4802; Appl. Phys. Lett., 201 1 , 98, 083302 and Chem. Commun., 2012, 48, 9580.

The TADF strongly depends on HOMO-LUMO separation in a single molecule. TADF materials have a sufficiently small energy gap between Si and Ti (AEST) to enable up- conversion of the triplet exciton from Ti to Si. This small AEST enables TADF materials to realize 100%of the exciton formation generated by electrical excitation at Si.

WO03/105538 relates to electroluminescent devices comprising organic layers that contain certain 2H-benzotriazole compounds. The 2H-benzotriazole compounds are suitable components of blue-emitting, durable, organo-electrouminescent layers. The following compounds are explicitly mentioned:

, especially

R 101 are independentl , Ci-

C24alkyl, especially Ci-Ci2alkyl, very especially tert-butyl, or

wherein X 51 , X 52 , Xss, β 5 anc | χ ββ are independently of each other fluorine, Ci- C2 4 alkyl, especially Ci-Ci2alkyl, very especially tert-butyl, C5-Ci2cycloalkyl, especially cy- clohexyl, which can optionally be substituted by one, or two Ci-Csalkyl groups, or 1- adamantyl, Ci-C2 4 perfluoroalkyl, especially Ci-Ci2perfluoroalkyl, such as CF3, C6- Ci 4 perfluoroaryl, especially pentafluorophenyl, N R 25 R 26 , wherein R 25 and R 26 are C6-Ci 4 aryl, especially phenyl, which can be substituted by one, or two Ci-C2 4 alkyl groups, or R 25 and

- N

R 26 together form a five or six membered heterocyclic ring, especially

— N \ —N

d embodiment WO2005/054212 discloses com

(IVb), or

or , R 25 and R 26 are C6-Ci4aryl, especially phenyl, 1-naphthyl, 2-naphthyl, which can optionally be substituted by one, or two d-Csalkyl groups, or C-i-Csalkoxy groups. The fol

preferably used as the light emitting material in the light emitting layer, optionally as a host or guest component.

Musubu lchikawa et al., J. Mater. Chem., 2011 , 21 , 11791-11799 describe new electron- transporting materials (ETMs) for organic light-emitting devices (OLEDs) based on ben- zo[1 ,2,3]triazole and two bipyridines. relates to benzotriazole derivatives represented by formula

(1 ), wherein An and A¾ represent an aromatic hydrocarbon group, an aromatic heterocyclic group, or the like; A represents a group which includes a pyridine ring. The derivatives exhibit electron injection and transport performance, and have hole- blocking ability. An object of the present invention is to provide a highly efficient and practically useful organic light-emitting element and an organic light-emitting material suitable for the organic light-emitting element. It has surprisingly been found that certain 2H-benzotriazole compounds emit delayed fluorescence and the use thereof in an organic light-emitting element provides a highly efficient organic EL element. Accordingly, the present invention relates to an organic light-emitting element, comprising a light-emitting layer compris

i) a compound of formula (I) as guest and a host mate- rial; or

ii) a compound of formula (I) as host and a fluorescent guest material, wherein

R 1 , R 2 , R 3 and R 4 are independently of each other H, D, F, CI, a Ci-C25alkyl group, a Ci- C25alkoxy group, a C6-Cioaryloxy group, or a donor group of formula

R5, Re, R 7 , R 8 and R 9 are independenlly of each other H, D, F, CI, a Ci-C 2 5alkyl group,

C25alkoxy group, a C6-Cioaryloxy group, a group of formula , (Xa),

(Xb), (Xc), or (Xd);

R 1 ' , R 2' , R 3' and R 4' are independently of each other H, D, F, CI, a Ci-C2salkyl group, a Ci- C25alkoxy group, or a C6-Cioaryloxy group; R 1 and R 2 together form a group of formula

R 1' and R 2' together form a group of formula

R 3 and R 4 together form a group of formula

R 3' and R 4' together form a group of formula

R 5 and R 6 together form a group of formula ; and/or

R 8 and R 9 together form a group of formula ;

A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 and A 8 are independently of each other H, D, F, CI, a Ci-C 25 alkyl group, or a donor group of formula (Xa), (Xb), (Xc), or (Xd);

A 9 , A , AH, A i2 , A 13 , A 14 , A15 and A16 are independently of each other H, D, F, CI, a Ci- C25alkyl group, or a donor group of formula (Xa), (Xb), (Xc), or (Xd);

X 1 and X 2 are independently of each other a single bond, O, S, N(R 15 ), C(=0), C(R 6 )(R 17 ), B(R i s), or Si(R 9 )(R 20 ) and

R 10 , R 11 , R 12 , R 13 , R 21 and R 2 ' are independently of each other H, D, F, CI, or a Ci-C 25 alkyl group;

R 4 , R 15 , R 16 , R 17 , R 18 , R 19 and R 20 are independently of each other H, D, a Ci-C 25 alkyl group, or a C6-Ci 4 aryl group, which can optionally be subituted by one, or more groups selected from a Ci-C2salkyl group, a Ci-C2salkoxy group and a C6-Cioaryloxy group;

with the proviso that at least one donor group of formula (Xa), (Xb), (Xc), or (Xd) is present in the compound of formula (I), characterized in that it emits delayed fluorescence. The present invention is also directed to the use of compounds of formula (I) for generating delayed fluorescence emission.

E-type delayed fluorescence fluorescence is defined herein as a process in which the first excited singlet state becomes populated by a thermally activated radiationless transition from the first excited triplet state.

Thermally activated delayed fluorescence (TADF, E-type delayed fluorescence) is a promising way to obtain a high efficiency of exciton formation by converting spin-forbidden triplet excitons up to the singlet level by the mechanism of reverse intersystem crossing (RISC). In a TADF emitter, the upconversion mechanism uses the vibronic energy that, at sufficiently high temperatures (> 300 K), allows all of the excitons in an OLED to eventually produce light through singlet decay. The organic light-emitting element offers an external quantum efficiency of more than 5%, especially more than 10 % and reduced efficiency roll-off characteristics at high luminance.

The compound of formula (I) has preferably a difference between excited singlet energy and excited triplet energy ((AEST) of 0.5 eV or less, more preferably AEST of 0.35 eV or less, i.e. of 0.01 to 0.5 eV, especially 0.01 to 0.35 eV.

The determination of AEST can be carried either by quantum mechanical calculations (for example TD-DFT (time dependent density functional theory) calculations, for example with commercially available Gaussian 09 or ADF Amsterdam Density Functional software pro- grams; for example as described in Adv. Mater. 2008, 20, 3325-3330), or experimentally.

Experimental determination of AEST:

i) AEST can be determined based on the information given in the following formula:

lnt(Si→So)/lnt(Ti→T 0 ) = k(Si)/k(Ti)exp(-AE/k B T).

The intensites lnt(Si→So) and lnt(Ti→To) can be determined spectroscopically by a spectrophotometer. A graph of the logarithmic intensity ratios lnt(Si→So)/lnt(Ti→To) measured at different temperatures versus the reciprocal of the absolute temperature T generally shows a straight line. The measurement is carried out in a temperature range from room tempera- ture (300 K) to 77 K to 4.2 K (the temperature can be adjusted by means of a cryostat). The respective transitions (Si→So) and (Ti→T 0 ) (band intensities) can be identified since the triplet transition is at lower energy than the singlet transition and increases in intensity with decreasing temperature. The measurements are usually performed in oxygen-free dilute solutions (about 10- 2 molL- 1 ) or thin films of the respective compounds or doped films com- prising the corresponding compounds.

The slope of the straight line mentioned above is -AE/k B T. With k B = 1.380 10- 23 JK- = 0.695 cm- 1 K- 1 , AEST can be determined. ii) AEST can also be determined by measuring the temperature dependency of the emission decay as known by a person skilled in the art. iii) An approximate estimation of AEST can be achieved by recording the fluorescence and phosphorescence spectra at low temperature (for example 77 K or 4.2 K using a cryostat). AEST then corresponds to an approximation of the energy difference between the high- energy rising edges of the fluorescence or phosphorescence band.

Fig. 1 : PL emission spectra of codeposited l (mCBP)

doped with 8.6 % by weight of compound (A-5)) recorded with a streak camera. Fluorescence (dotted line) and TADF (thin line) spectra are recorded at 298 K using a time range of 0 to 30 ns and a time range of > 1 \is, respectively. The phosphorescence (thick line) spectrum is measured at 8 K, by using a time range of 20 to 30 ms and omitting the prompt fluorescence.

Fig. 2: Photoluminescence (PL, dotted line) and electroluminescence (EL, thin line; at 10 mA/cm 2 ) spectra measured from a codeposited film (mCBP doped with 8.6 % by weight of compound (A-5)) and the OLED of Application Example 2, repectively.

The compounds of formula (I) contain preferably one, or two donor groups of formula (Xa), (Xb), (Xc) and/or (Xd).

Compounds of formula (I) are preferred, wherein R 1 , R 2 , R 3 , R 4 , R 6 , R 7 , R 8 and R 9 are independently of each other H, a Ci-C2salkyl group, a Ci-C2salkoxy group, a C6-Cioaryloxy

R 1 and R 2 together form a group of formula

R 8 and R 9 together form a group of formula

R 5 is H, a Ci-C25alkyl group, a group of formula , or a donor group of formula (Xa), (Xb), (Xc), or (Xd);

X 1 and X 2 are independently of each other a single bond, O, S, C(O), N(R 15 ), or

C(R 6 )(R 17 ); and

Rio Rii R12_ R13 R21 anc | R21' are independently of each other H, or a Ci-C 2 5alkyl group;

R ently of each other a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, a Ci-C2salkyl group, a Ci-C2salkoxy group, or a C6-Cioaryloxy group;

with the proviso that at least one of R , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 is a donor group of formula (Xa), (Xb), (Xc), or (Xd).

A I) compounds of formula

(la) are more preferred, wherein

R 1 and R 2 are independently of each other H, or a Ci-C2salkyl group, or

R 1 and R 2 together form a group of formula R 3 , R 7 and R 8 are independently of each other H, a Ci-C25alkyl group, or a donor group of

f

R 5 is H, a Ci-C25alkyl group, a group of formula or a donor group of formula (Xa), (Xb), (Xc), or (Xd);

R9 is H, or

R 8 and R 9 together form a group of formula

X 1 and X 2 are independently of each other a single bond, O, S, N(R 15 ), or C(R 16 )(R 17 ); R 10 , R 11 , R 12 , R 13 , R 21 and R 21' are independently of each other H, or a Ci-C 2 5alkyl group;

1 4 and R 15 are independently of each other a group of formula or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group;

with the proviso that at least one of R 3 , R 5 and R 7 is a donor group of formula (Xa), (Xb),

(Xc), or (Xd). Among the compounds of formula (la) compounds of formula

(la') are more preferred, wherein

R 1 and R 2 are independently of each other H, or a Ci-C25alkyl group, or

R 1 and R 2 together form a group of formula

R 3 is H, a Ci-C2salkyl group, or a donor group of formula (Xa),

R 7 is H, a Ci-C25alkyl group, or a donor group of formula (Xa), (Xb), (Xc), or (Xd);

R 8 and R 9 are H, or

R 8 and R 9 together form a group of formula

X 1 and X 2 are independently of each other a single bond, O, S, N(R 15 ), or C(R 16 )(R 17 ); R 10 , R 11 , R 12 , R 13 , R 21 and R 21' are independently of each other H, or a Ci-C 2 5alkyl group;

1 4 and R 15 are independently of each other a group of formula or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group; with the proviso that at least one of R 3 and R 7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd).

In addition, among the compounds of formula (la) compounds of formula

R 3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R 7 is H;

R 3 and R 7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la"), wherein

R 5 is H;

R 8 and R 9 together form a group of formula

R 3 is H and R 7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

R 3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R 7 is H; or

R 3 and R 7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la"), wherein

R 3 , R 7 , R 8 and R 9 are H;

R 5 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la'"), wherein

R 3 is H and R 7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

R 3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R 7 is H; or

R 3 and R 7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or (la'"), wherein

R 3 is H and R 7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

R 3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R 7 is H ; or

R 3 and R 7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la'"), wherein

and R 9 together form a group of formula ;

R 3 is H and R 7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

R 3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R 7 is H ; or

R 3 and R 7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

a compound of formula (la'"), wherein

R 3 , R 7 , R 8 and R 9 are H ;

R 5 is a donor group of formula (Xa), (Xb), (Xc), or (Xd);

X 1 and X 2 are independently of each other a single bond, O, S, C(O), N(R 15 ), or

C(R 6 )(R 17 );

R 10 , R 11 , R 12 , R 13 , R 21 and R 21 ' are independently of each other H, or a Ci-C 2 5alkyl group;

R ently of each other a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group. In said embodiment compounds of formula (la") are more prefer R 8 and R 9 are H ;

R 3 is H and R 7 is a donor group of formula (Xa),

R 3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R 7 is H; or

R 3 and R 7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd).

In said embodiment compounds of formula (la'") are more preferred, wherein

R 5 , R 8 and R 9 are H;

R 3 is H and R 7 is a donor group of formula (Xa), (Xb), (Xc), or (Xd); or

R 3 is a donor group of formula (Xa), (Xb), (Xc), or (Xd) and R 7 is H; or

R 3 and R 7 are a donor group of formula (Xa), (Xb), (Xc), or (Xd) and

X 1 and X 2 are independently of each other a single bond, O, S, C(O), N(R 15 ), or

C(R 6 )(R 17 );

R 10 , R 11 , R 12 , R 13 , R 21 and R 21' are independently of each other H, or a Ci-C 2 5alkyl group;

R ently of each other a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C25alkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group.

In an additional preferred embodiment the present invention is directed to organic light- e s of formula

ein

group of formula (Xb),

compounds of formula (lb), wherein

R 5 is a donor group of formula (Xa), (Xb), (Xc), or (Xd), and

R 7 and R 8 are are independently of each other H, or a Ci-C25alkyl group; and

X 1 and X 2 are independently of each other a single bond, O, S, C(O), N(R 15 ), or

C(R 6 )(R 17 );

R 10 , R 11 , R 12 , R 13 , R 21 and R 21' are independently of each other H, or a Ci-C 2 5alkyl group;

ently of each other a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group.

In an additional preferred embodiment the present invention is directed to organic light- emitting elements, comprising compounds of formula

(lc), wherein

R 1 and R 4 are a donor group of formula (Xa), (Xb),

X 1 and X 2 are independently of each other a single bond, O, S, C(O), N(R 15 ), or

C(R 6 )(R 17 );

R 8 and R 9 are H, or

R 8 and R 9 together form a group of formula

Rio Rii R12 R13 R21 anc | R21' are independently of each other H, or a Ci-C 25 alkyl group;

R ently of each other a group of formula or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R22 and R 23 are independently of each other H, or a Ci-C2salkyl group.



Examples of the donor group of formula (Xb) are groups of formula

and

are preferred. A group of formula is most preferred.

Exa

and . Groups of formula and

are most preferred

Among the donor groups of formula (Xd) a group of fomula is preferred.

The donor group is preferably a donor group of formula (Xa), wherein X 1 is a single bond,

N

O, S, C(CH 3 )(CH 3 ), C(=0), -o ; or a donor group of formula (Xb), wherein X 2 is a single bond and R 12 is H; or a donor group of formula (Xc), wherein R 13 is a group of formu-

la and R 14 is a group of formula , or

or a donor group of formula (Xd), wherein R 21 and R 21' are H.

Among the donor groups of formula (Xa), (Xb), (Xc) and (Xd) donor groups of formula (Xa) and (Xc) are preferred. Donor groups of formula (Xa) are most preferred.

and are most preferred.

20

21

5

(A-45), (A-46), 





Among compounds of formula (la) those are preferred uted by donor

g

, such as, for example, compounds (A-1 ), (A-2), (A-3), (A-4), (A-5), (A-6), (A-7), (A-8), (A-9), (A-10), (A-11 ), (A-12), (A- 13), (A-14), (A-15), (A-16), (A-17), (A-18), (A-19), (A-20), (A-21 ), (A-22), (A-61 ), (A-62), (A- 63), (A-64), (A-71 ), (A-72), (A-73), (A-74), (A-81 ), (A-82), (A-83), (A-84), (A-91 ), (A-92), (A- 93), (A-94), (A-101 ), (A-102), (A-103), (A-104), (A-111 ), (A-112), (A-113) and (A-114).

Examples of compounds of formula (lb) are shown below:

30

Among compounds of formula (lc) those are preferred which bstituted by donor

g

or example, compounds (C-1), (C-2), (C-3) and (C-4).

Ci-C25alkyl (Ci-Cisalkyl) is typically linear or branched, where possible. Examples are methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert.-butyl, n-pentyl, 2-pentyl, 3- pentyl, 2,2-dimethylpropyl, 1 ,1 ,3,3-tetramethylpentyl, n-hexyl, 1-methylhexyl, 1 ,1 ,3,3,5,5- hexa methyl hexyl, n-heptyl, isoheptyl, 1 ,1 ,3,3-tetramethylbutyl, 1-methylheptyl, 3-methyl- heptyl, n-octyl, 1 ,1 ,3,3-tetramethylbutyl and 2-ethylhexyl, n-nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, or octadecyl. d-Csalkyl is typically methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert.-butyl, n-pentyl, 2-pentyl, 3-pentyl, 2,2-dimethyl-propyl, n-hexyl, n-heptyl, n-octyl, 1 ,1 ,3,3-tetramethylbutyl and 2- ethylhexyl. Ci-C4alkyl is typically methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso- butyl, tert.-butyl.

Ci-C25alkoxy groups (Ci-Cisalkoxy groups) are straight-chain or branched alkoxy groups, e.g. methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, tert-butoxy, amyloxy, isoamyloxy or tert-amyloxy, heptyloxy, octyloxy, isooctyloxy, nonyloxy, decyloxy, un- decyloxy, dodecyloxy, tetradecyloxy, pentadecyloxy, hexadecyloxy, heptadecyloxy and octadecyloxy. Examples of d-Csalkoxy are methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, tert.-butoxy, n-pentyloxy, 2-pentyloxy, 3-pentyloxy, 2,2- dimethylpropoxy, n-hexyloxy, n-heptyloxy, n-octyloxy, 1 ,1 ,3,3-tetramethylbutoxy and 2- ethylhexyloxy, preferably Ci-C4alkoxy such as typically methoxy, ethoxy, n-propoxy, iso- propoxy, n-butoxy, sec-butoxy, isobutoxy, tert.-butoxy.

C6-Cioaryl, which optionally can be substituted, is typically phenyl, naphthyl, especially 1- naphthyl, or 2-naphthyl,or biphenylyl, which may be unsubstituted or substituted by one, or more d-Csalkyl, d-Csalkoxy and/or di-doaryloxy groups, especially d-Csalkyl, d-Cealkoxy groups.

C6-doaryloxy, which optionally can be substituted by one, or more d-Csalkyl and/or d-Cealkoxy groups, is typically phenoxy, 1-naphthoxy, or 2-naphthoxy. The compounds of formula (I) can be used as host in combination with a fluorescent guest material in the emitting layer of an organic EL element. Known fluorescent materials are usable as the fluorescent guest material. Examples of the fluorescent guest material include a bisarylamino naphthalene derivative, an aryl-substituted naphthalene derivative, a bisarylamino anthracene derivative, an aryl-substituted anthracene derivative, a bisarylamino pyrene derivative, an aryl-substituted pyrene derivative, a bisarylamino chrysene derivative, an aryl-substituted chrysene derivative, a bisarylamino fluoranthene derivative, an aryl-substituted fluoranthene derivative, an indenoperylene derivative, a pyrromethene boron complex compound, a compound having a pyrromethene skeleton or a metal complex thereof, a diketopyrrolopyrrole derivative, and a perylene derivative. Examples are 2,5,8,11- tetra-tert-butylperylene (TBPe), 9, 10-bis[N,N -di-(p -tolyl)-amino]anthracene (TTPA), 2,8-di- tert -butyl-5, 11-bis(4-tert -butylphenyl)-6,12- diphenyltetracene (TBRb) and dibenzo{[f,f ]- 4,4',7,7'-tetraphenyl}diindeno[1 ,2,3- cd :1 ',2',3'-lm jperylene (DBP). In case of using the compound of formula (I) as host material, the content of the compound of formula (I) in the light-emitting layer falls within the range of 51 to 99 wt%, preferably 80 to 99 wt%.

Alternatively, the compounds of formula (I) can be used as guest in combination with a host material in the emitting layer of an organic EL element. In said embodiment the compound of formula (I), i.e. the organic light-emitting material, has preferably a difference between excited singlet energy and excited triplet energy ((AEST) of 0.5 eV or less, more preferably AEST of 0.35 eV or less. The organic light-emitting material may be used alone in the light- emitting layer. However, as necessary, for the purpose of, for example, confining, in the organic light-emitting material, singlet excitons and triplet excitons generated in the organic light-emitting material, the organic light-emitting material of the present invention and an organic compound which has a higher value of at least any one of excited singlet energy and excited triplet energy than those of the organic light-emitting material and serves as a host material are preferably used in the light-emitting layer. At least any one of the excited singlet energy (Sih) and excited triplet energy (Tih) of the host compound is preferably higher by 0.1 eV or more, particularly preferably higher by 0.2 eV or more than the excited singlet energy (Si g ) and excited triplet energy (Ti g ) of the organic light-emitting material of the present invention. That is, it is preferred that one or both of (Sih) - (Si g ) > 0.1 eV and (Tih) - (Ti g ) > 0.1 eV be satisfied and it is more preferred that one or both of (Sih) - (Si g ) > 0.2 eV and (Tm) - (Ti B ) >0.2 eV be satisfied. The organic EL element of the present invention has, as essential layers, an anode, a hole- transporting layer, a light-emitting layer, and a cathode.

Further, the organic EL element of the present invention may have, as layers other than the essential layers, an electron-transporting layer, an electron-injecting layer, an electron- blocking layer, a hole-blocking layer, and an exciton element layer. In addition, the hole- transporting layer may be a hole-injecting/transporting layer having a hole-injecting function and the electron-transporting layer may be an electron-injecting/transporting layer having an electron-injecting function. The organic EL element of the present invention may comprise in this order: a substrate, an anode, a hole-injecting layer, a hole-transporting layer, a light-emitting layer, an electron- transporting layer and a cathode. Alternatively, the cathode, the electron-transporting layer, the light-emitting layer, the hole-transporting layer, and the anode may be laminated on the substrate in the stated order.

Substrate

The organic EL element of the present invention is preferably supported by a substrate. The substrate is not particularly limited and may be any substrate which is conventionally used in an organic EL element. For example, a substrate formed of glass, transparent plastic, quartz, or the like may be used.

Anode

Preferably used as the anode in the organic EL element is one using, as an electrode sub- stance, any of a metal, an alloy, an electrically conductive compound, and a mixture thereof with a high work function (4 eV or more). Specific examples of such electrode substance include metals such as Au and conductive transparent materials such as Cul, indium tin oxide (ITO), Sn02, and ZnO. Further, a material capable of producing an amorphous transparent conductive film such as IDIXO (Ιη2θ3-ΖηΟ) may be used. In the production of the anode, it is possible to form any of those electrode substances into a thin film by a method such as vapor deposition or sputtering, and then form a pattern having a desired shape by a photolithographic method. Alternatively, in the case of using a coatable substance such as an organic conductive compound, it is also possible to employ a wet film-forming method of a printing mode, a coating mode, or the like.

Cathode

Meanwhile, used as the cathode is one using, as an electrode substance, any of a metal (referred to as electron-injecting metal), an alloy, an electrically conductive compound, and a mixture thereof with a low work function (4 eV or less). Specific examples of such elec- trode substance include sodium, a sodium-potassium alloy, magnesium, lithium, a magnesium/copper mixture, a magnesium/silver mixture, a magnesium/aluminum mixture, a magnesium/indium mixture, an aluminum/aluminum oxide (AI2O3) mixture, indium, a lithium/aluminum mixture, and a rare earth metal. Of those, from the viewpoints of electron- injecting property and durability against oxidation and the like, a mixture of an electron- injecting metal and a second metal, which has a work function value higher than that of the electron-injecting metal and is a stable metal, such as a magnesium/silver mixture, a magnesium/aluminum mixture, a magnesium/indium mixture, an aluminum/aluminum oxide (AI2O3) mixture, a lithium/aluminum mixture, or aluminum is suitable. It should be noted that a case where any one of the anode and the cathode of the organic EL element is transpar- ent or translucent in order to transmit emitted light is advantageous because light emission luminance is improved.

Light-emitting layer

The light-emitting layer is a layer which emits light after excitons have been generated through the recombination of holes and electrons injected respectively from an anode and a cathode. The light-emitting layer preferably includes an organic light-emitting material and a host material. As the organic light-emitting material, there may be used one kind or two or more kinds selected from the compounds of formula (I). In order that the organic EL element of the present invention exhibits high luminous efficiency, it is important to confine, in the organic light-emitting material, singlet excitons and triplet excitons generated in the organic light-emitting material. Accordingly, it is preferred to use the host material in addition to the organic light-emitting material in the light-emitting layer. As the host material, there may be used an organic compound having a higher value of at least any one of excited singlet energy and excited triplet energy than those of the organic light-emitting material of the present invention. This allows singlet excitons and triplet excitons generated in the organic light-emitting material of the present invention to be confined in the molecule of the organic light-emitting material of the present invention and allows the luminous efficiency to be exhibited sufficiently. In the organic EL element of the present invention, light is emitted from the organic light-emitting material of the present invention included in the light-emitting layer.

In case of using the host material, the content of the organic light-emitting material of the present invention in the light-emitting layer fall within the range of 1 to 50 wt%, preferably 1 to 20 wt%.

The host material in the light-emitting layer is preferably an organic compound which has a hole-transporting ability and/or an electron-transporting ability, prevents an emission wavelength from becoming longer, and has a high glass transition temperature. The host material may be a polymer, for example poly(N-vinylcarbazole) or polysilane. The host material may, however, be a small molecule, for example 4,4'-N,N'- dicarbazolebiphenyl (CDP=CBP), 2,6-bis(N-carbazolyl)pyr iephenyl (mCP), 3,3-di(9H-

or tertiary aromatic amines, for example 4-carbazol-9-yl-N,N-bis(4-carbazol-9- ylphenyl)aniline (TCTA). Injecting layer

The injecting layer refers to a layer to be provided between an electrode and an organic layer for the purposes of reducing a driving voltage and improving a light emission luminance. The injecting layer includes a hole-injecting layer and an electron-injecting layer, and may be provided between the anode and the light-emitting layer or the hole- transporting layer, and between the cathode and the light-emitting layer or the electron- transporting layer. The injecting layer may be provided as necessary.

Customarily used hole injection materials include a-NPD, CuPc, MTDATA, or dipyra- zino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitril e (HAT-CN). Polymeric hole- injection materials

can be used such as poly(N-vinylcarbazole) (PVK), polythiophenes, polypyrrole, polyani- line, self-doping polymers, such as, for example, sulfonated poly(thiophene-3-[2[(2- methoxyethoxy)ethoxy]-2,5-diyl) (Plexcore ® OC Conducting Inks commercially available from Plextronics), and copolymers such as poly(3,4-ethylenedioxythiophene)/poly(4- styrenesulfonate) also called PEDOT/PSS.

Lithium-comprising organometallic compounds such as 8-hydroxyquinolatolithium (Liq), CsF, NaF, KF, CS2CO3 or LiF may be applied between the electron transport layer and the cathode as an electron injection layer in order to reduce the operating voltage. Blocking layer

The blocking layer is capable of blocking charges (electrons or holes) and/or excitons present in the light-emitting layer from diffusing to the outside of the light-emitting layer. The electron-blocking layer may be arranged between the light-emitting layer and the hole- transporting layer, and blocks electrons from passing through the light-emitting layer toward the hole-transporting layer. Similarly, the hole-blocking layer may be arranged between the light-emitting layer and the electron-transporting layer, and blocks holes from passing through the light-emitting layer toward the electron-transporting layer. The blocking layer may also be used for blocking excitons from diffusing to the outside of the light-emitting layer. That is, the electron-blocking layer and the hole-blocking layer may each have a function of an exciton-blocking layer as well. The electron-blocking layer or exciton-blocking layer as used herein is meant to include a layer having a function of an electron-blocking layer and an exciton-blocking layer in one layer.

Hole-blocking layer

The hole-blocking layer has a function of the electron-transporting layer in a broad sense. The hole-blocking layer has a role in blocking holes from reaching the electron-transporting layer while transporting electrons. This can improve the probability of recombination of electrons and holes in the light-emitting layer. As a material for the hole-blocking layer, a material for the electron-transporting layer to be described below may be used as neces- sary.

Electron-blocking layer

The electron-blocking layer has a function of transporting holes in a broad sense. The electron-blocking layer has a role in blocking electrons from reaching the hole-transporting layer while transporting holes. This can improve the probability of recombination of electrons and holes in the light-emitting layer.

Exciton-blocking layer

The exciton-blocking layer refers to a layer for blocking excitons, which are generated by the recombination of holes and electrons in the light-emitting layer, from diffusing to a charge-transporting layer. The insertion of this layer allows excitons to be efficiently confined in the light-emitting layer, which can improve the luminous efficiency of an element. The exciton-blocking layer may be inserted on any of the anode side and the cathode side of the adjacent light-emitting layer, and may be simultaneously inserted on both of the sides. That is, when the exciton-blocking layer is provided on the anode side, the layer may be inserted between the hole-transporting layer and the light-emitting layer so as to be adjacent to the light-emitting layer. When the exciton-blocking layer is inserted on the cathode side, the layer may be inserted between the light-emitting layer and the cathode so as to be adjacent to the light-emitting layer. Further, the hole-injecting layer, the electron-blocking layer, and the like may be provided between the anode and the exciton-blocking layer adjacent to the anode side of the light-emitting layer, and the electron-injecting layer, the electron-transporting layer, the hole-blocking layer, and the like may be provided between the cathode and the exciton-blocking layer adjacent to the cathode side of the light-emitting layer. In the case of providing the blocking layer, it is preferred that at least any one of the excited singlet energy and excited triplet energy of a material to be used as the blocking layer be higher than the excited singlet energy and excited triplet energy of a light-emitting material.

Hole blocker materials typically used are 2,6-bis(N-carbazolyl)pyridine (mCPy), 2,9- dimethyl-4,7-diphenyl-1 ,10-phenanthroline (bathocuproin, (BCP)), bis(2-methyl-8- quinolinato)-4-phenylphenylato)aluminum(lll) (BAIq), phenothiazine S,S-dioxide derivates and 1 ,3,5-tris(N-phenyl-2-benzylimidazolyl)benzene) (TPBI), TPBI also being suitable as electron-transport material. Further suitable hole blockers and/or electron conductor materials are 2,2',2"-(1 ,3,5-benzenetriyl)tris(1-phenyl-1-H-benzimidazole), 2-(4-biphenylyl)-5-(4- tert-butylphenyl)-1 ,3,4-oxadiazole, 8-hydroxyquinolinolatolithium, 4-(naphthalen-1-yl)-3,5- diphenyl-4H-1 ,2,4-triazole, 1 ,3-bis[2-(2,2'-bipyridin-6-yl)-1 ,3,4-oxadiazo-5-yl]benzene, 4,7- diphenyl-1 , 10-phenanthroline, 3-(4-biphenylyl)-4-phenyl-5-tert-butylphenyl-1 ,2,4-triazole, 6,6'-bis[5-(biphenyl-4-yl)-1 ,3,4-oxadiazo-2-yl]-2,2'-bipyridyl, 2-phenyl-9, 10-di(naphthalene- 2-yl)anthracene, 2,7-bis[2-(2,2'-bipyridin-6-yl)-1 ,3,4-oxadiazo-5-yl]-9,9-dimethylfluorene, 1 ,3-bis[2-(4-tert-butylphenyl)-1 ,3,4-oxadiazo-5-yl]benzene, 2-(naphthalene-2-yl)-4,7- diphenyl-1 , 10-phenanthroline, tris(2,4,6-trimethyl-3-(pyridin-3-yl)phenyl)borane, 2,9- bis(naphthalene-2-yl)-4,7-diphenyl-1 , 10-phenanthr hthalene-2-

yl)phenyl)-1 H-imidazo[4,5-f][1 ,10]phenanthroline, (DPEPO) and 2,4,6-tris(biphenyl-3-yl)-1 ,3,5-triazine (T2T).

Hole-transporting layer

The hole-transporting layer is formed of a hole-transporting material having a function of transporting holes. The hole-transporting layer may be provided in a single layer or a plurality of layers.

The hole-transporting material has any of hole-injecting or -transporting property and electron-blocking property, and may be an organic material or an inorganic material. An applicable known hole-transporting material is exemplified by a triazole derivative, an oxadiazole derivative, an imidazole derivative, a carbazole derivative, an indolocarbazole derivative, a polyarylalkane derivative, a pyrazoline derivative, a pyrazolone derivative, a phenylenedia- mine derivative, an arylamine derivative, an amino-substituted chalcone derivative, an oxa- zole derivative, a styrylanthracene derivative, a fluorenone derivative, a hydrazone derivative, a stilbene derivative, a silazane derivative, an aniline-based copolymer, or a conducting polymeric oligomer, particularly a thiophene oligomer. However, preferably used are a porphyrin compound, an aromatic tertiary amine compound, and a styrylamine compound, and more preferably used is an aromatic tertiary amine compound. Customarily used hole-

(4-phenyl-N-(4-phenylphenyl)-N-[4-[4-(N-[4-(4-phenyl- phenyl)phenyl]anilino)phenyl]phenyl]aniline), (4-phenyl-N-(4- (4-phenyl-N-(4-phenylphenyl)anilino)phenyl]phenyl]aniline),

(9-phenylcarbazol-3-yl)phenyl]-N-(4-

phenylphenyl)aniline), (1 , 1 ',3,3'-tetraphenylspiro[1 ,3,2-benzodiazasilole-

2,2'-3a,7a-dihydro-1 ,3,2-benzodiazasilole]),

(N2,N2,N2',N2',N7,N7,N7',N7'-octakis(p^ 4,4'- bis[N-(1-naphthyl)-N-phenylamino]biphenyl (a-NPD), N,N'-diphenyl-N,N'-bis(3- methylphenyl)-[1 ,1 '-biphenyl]-4,4'-diamine (TPD), 1 ,1-bis[(di-4-tolylamino)phenyl]- cyclohexane (TAPC), N,N'-bis(4-methylphenyl)-N,N'-bis(4-ethylphenyl)-[1 ,1 '-(3,3'-dimethyl)- biphenyl]-4,4'-diamine (ETPD), tetrakis(3-methylphenyl)-N,N,N',N'-2,5-phenylenediamine (PDA), a-phenyl-4-N,N-diphenylaminostyrene (TPS), p-(diethylamino)benzaldehyde diphe- nylhydrazone (DEH), triphenylamine (TPA), bis[4-(N,N-diethylamino)2-methylphenyl](4- methylphenyl)methane (MPMP), 1-phenyl-3-[p-(diethylamino)styryl]5-[p- (diethylamino)phenyl]pyrazoline (PPR or DEASP), 1 ,2-trans-bis(9H-carbazol9-yl)- cyclobutane (DCZB), N,N,N',N'-tetrakis(4-methylphenyl)-(1 ,1 '-biphenyl)-4,4'-diamine (TTB), fluorine compounds such as 2,2',7,7'-tetra(N,N-di-tolyl)amino9,9-spirobifluorene (spiro- TTB), N,N'-bis(naphthalen-1-yl)-N,N'-bis(phenyl)9,9-spirobifluoren e (spiro-NPB) and 9,9- bis(4-(N,N-bis-biphenyl-4-yl-amino)phenyl-9Hfluorene, benzidine compounds such as Ν,Ν'- bis(naphthalen-1-y '-bis(phenyl)benzidine and porphyrin compounds such as copper

phthalocyanines, (BPY-TP2), (Tris-PCz) and CzSi. In addition, polymeric hole-injection materials can be used such as poly(N-vinylcarbazole) (PVK), polythiophenes, polypyrrole, polyaniline, self-doping polymers, such as, for example, sulfonated poly(thiophene-3-[2[(2- methoxyethoxy)ethoxy]-2,5-diyl) (Plexcore® OC Conducting Inks commercially available from Plextronics), and copolymers such as poly(3,4-ethylenedioxythiophene)/poly(4- styrenesulfonate) also called PEDOT/PSS.

Electron-transporting layer

The electron-transporting layer is formed of a material having a function of transporting electrons. The electron-transporting layer may be provided in a single layer or a plurality of layers.

An electron-transporting material (may also serve as a hole-blocking material) has only to have a function of transporting electrons, which are injected from the cathode, to the light- emitting layer. An applicable electron-transporting layer is exemplified by a nitro-substituted fluorene derivative, a diphenylquinone derivative, a thiopyran dioxide derivative, car- bodiimide, a fluorenylidenemethane derivative, an anthraquinodimethane derivative, an anthrone derivative, or an oxadiazole derivative. In addition, in oxadiazole derivative, a thiadiazole derivative in which an oxygen atom of an oxadiazole ring is substituted by a sulfur atom, or a quinoxaline derivative having a quinoxaline ring known as an electron- withdrawing group may also be used as the electron-transporting material. In addition, a polymer material obtained by introducing any of those materials into a polymer chain, or a polymer material including any of those materials in a polymer main chain may also be used. Suitable electron-transporting materials comprise 1 ,3,5-tris(N-phenyl-2-

as tris(8-hydroxyquinolato)aluminum (Alq3), compounds based on phenanthroline such 2,9-dimethyl-4,7-diphenyl-1 , 10-phenanthroline (DDPA = BCP), 4,7-diphenyl-1 , 10- phenanthroline (Bphen), 2,4,7,9-tetraphenyl-1 , 10-phenanthroline, 4,7-diphenyl-1 , 10- phenanthroline (DPA) or phenanthroline derivatives disclosed in EP1786050, in EP1970371 , or in EP1097981 , and azole compounds such as 2-(4-biphenylyl)-5-(4-t- butylphenyl)-1 ,3,4-oxadiazole (PBD) and 3-(4-biphenylyl)-4phenyl-5-(4-t-butylphenyl)-1 ,2,4- triazole (TAZ). Examples of possible element structures are shown below:

ITO (100nm) / a-NPD (35nm) / CBP: 6 % by weight cpd. of formula (I) (15nm) / TPBi (65nm) / LiF (0.8nm) / Al (80nm)

ITO (100nm) / a-NPD (40nm) / mCP / PPT: 6 % by weight cpd. of formula (I) (20nm) / PPT (40nm) / LiF (0.8nm) / AI (80nm)

ITO (30-1 OOnm) / a-NPD (60nm) / mCP: 6 % by weight cpd. of formula (I) (20nm) / Bphen (40nm) / MgAg (100nm) / Ag (20nm) ITO (30-1 OOnm) / a-NPD (60nm) / PYD2: 6 % by weight cpd. of formula (I) (20nm) / Bphen (40nm) / MgAg (100nm) / Al (20nm)

ITO/a-NPD (35 nm)/6 % by weight cpd. of formula (I) :CBP (15 nm)/TPBi (65 nm)/LiF (0.8 nm)/AI (80 nm)

ITO (100nm) / HAT-CN (10nm) / Tris-PCz (30nm) / CBP: 3, 6, 10, or 15 % by weight cpd. of formula (I) (30nm) / BPY-TP2 (40nm) / LiF (0.8nm) / Al (100nm)

ITO (100nm) / a-NPD (35nm) / CBP (10nm) / DPEPO: 6 to 12 % by weight cpd. of formula (l) (15nm) / DPEPO (1 Onm) / TPBi (65nm) / LiF (0.5nm) / Al (80nm)

ITO (100nm)/ HAT-CN (10nm)/ Tris-PCz (30nm)/ mCBP: 6 to 12 % by weight cpd. of formula (I) (30nm)/ T2T (10nm)/ Bpy-TP2 (40nm)/ LiF (0.8nm)/ Al (100nm) ITO (100nm)/ a-NPD (30nm)/ TCTA (20nm)/ CzSi (10nm) / DPEPO: 6 to 12 % by weight cpd. of formula (I) (20nm)/ DPEPO (10nm)/ TPBi (30nm)/ LiF (0.8nm)/ Al (100nm)

ITO: indium/tin oxide; a-NPD: 4,4'-bis[N-(1-naphthyl)-N-phenylamino]biphenyl;

CBP: 4,4'-N,N'-dicarbazolebiphenyl; TPBi: zolyl)benzene;

mCP: 2,6-bis(N-carbazolyl)pyridine; PPT:

Bphen: 4,7-diphenyl- 1 , 10-phenanthroline; PYD2: ; HAT-CN:

ne-2,3,6,7,10,11-hexacarbonitrile; Tris-PCz:

The organic EL element emits light when an electric field is applied between an anode and a cathode of the resultant element.

The organic EL element of the present invention may be applied to any of a single element, an element formed of a structure with arrangement in an array fashion, and a structure in which an anode and a cathode are arranged in an X-Y matrix fashion.

According to the present invention, there is provided an element having significantly improved luminous efficiency as compared to a conventional element using light emission from a singlet state by incorporating the organic light-emitting material having a specific skeleton of the present invention into the light-emitting layer. The element can exhibit excellent performance when being applied to a full-color or multi-color panel. The element may also be utilized in a backlight, lighting, and the like.

C

(I), wherein R , R2, R3 and R 4 are independently of each other H , D, F, CI, a Ci-C 2 5alkyl group, a Ci- C2 5 alkoxy group, a Ce-doaryloxy group, or a donor group of formula

R5, R 6 , R 7 , R8 and R 9 are independenlly of each other H, D, F, CI, a CrC 2 5alkyl group, a Ci-

C2 5 alkoxy group, a Ce-Cioaryloxy group, a group of formula , (Xa),

(Xb), or (Xd);

R ', R 2 ', R 3 ' and R 4 ' are independently of each other H , D, F, CI, a Ci-C2salkyl group, a Ci- C2 5 alkoxy group, or a C6-Cioaryloxy group;

R 1 and R 2 together form a group of formula

R 1 ' and R 2 ' together form a group of formula

R 3 and R 4 together form a group of formula

R 3' and R 4 ' together form a group of formula

R 5 and R 6 together form a group of formula ; and/or R 8 and R 9 together form a group of formula ;

A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 and A 8 are independently of each other H, D, F, CI, a Ci-C 25 alkyl group, or a donor group of formula (Xa), (Xb), or (Xd);

A 9 , A , A H , A12, A 13 , A14 Ais and Aie are independently of each other H, D, F, CI, a Ci- C25alkyl group, or a donor group of formula (Xa), (Xb), or (Xd);

X i and X 2 are independently of each other O, S, N(R i s), C(R 6 )(R 17 ), B(R i8 ), or Si(R 9 )(R 2 o) and

R 10 , R 11 , R 12 , R 21 and R 2 ' are independently of each other H, D, F, CI, or a Ci-C 25 alkyl group;

R 15 , R 16 , R 17 , R 18 , R 19 and R 20 are independently of each other H, a Ci-C 2 5alkyl group, or a C6-Ci 4 aryl group;

with the proviso that at least one donor group of formula (Xa), (Xb), or (Xd) is present in the compound of formula (I), are new and form a further subject of the present invention. Compounds of formula (I) are preferred, wherein

R 1 , R 2 , R 3 , R 4 , Re, R 7 , R 8 and R 9 are independently of each other H, a Ci-C 2 5alkyl group, a C

(Xd); or

R and R 2 together form a group of formula ; and/or

R 8 and R 9 together form a group of formula

R 5 is H, a Ci-C25alkyl group, a group of formula , or a donor group of formula (Xa), (Xb), or (Xd);

X 1 and X 2 are independently of each other O, S, N(R 15 ), or C(R 6 )(R 17 ); and

R 10 , R 11 , R 12 , R 21 and R 21 ' are independently of each other H, or a Ci-C 2 5alkyl group;

R 5 is a group of formula , or ;

R 16 and R 17 are independently of each other H, a Ci-C25alkyl group;

R22 and R 23 are independently of each other H, a Ci-C2salkyl group, a Ci-C2salkoxy group, or a C6-Cioaryloxy group;

with the proviso that at least one of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 is a donor group of formula (Xa), (Xb), or (Xd).

I ent invention is directed to compounds of formula

R 1 and R 2 are independently of each other H, or a Ci-C2salkyl group, or

R and R 2 together form a group of formula ;

group, or a donor group of

formula (Xa), (Xb), or (Xd);

R9 is H, or

R 8 and R 9 together form a group of formula χι and X 2 are independently of each other O, S, N(R i s), or C(R 6 )(R 17 );

Rio I I _ R12 R21 anc | R21' C 25 alkyl group;

R 15 is a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group;

with the proviso that at least one of R 3 , R 5 and R 7 is a donor group of formula (Xa), (Xb), or (Xd).

Compounds of formula (la') are more preferred, wherein R 1 and R 2 are independently of each other H, or a Ci-C2salkyl group, or

R 1 and R 2 together form a group of formula

R 3 is H, a Ci-C25alkyl group, or a donor group of formula (Xa),

R 7 is H, a Ci-C 25 alkyl group, or a donor group of formula (Xa), (Xb),

R 8 and R 9 are H, or

R 8 and R 9 together form a group of formula

Xi and X 2 are independently of each other O, S, N(R i s), or C(R 6 )(R 17 );

Rio I I _ R12 R21 anc | R21' are independently of each other H, or a Ci-C 25 alkyl group;

R 15 is a a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C25alkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C25alkyl group;

with the proviso that at least one of R 3 and R 7 is a donor group of formula (Xa), (Xb), or (Xd). Compounds of formula

in

and R 5 are H and R 7 is a donor group of formula (Xa),

R 3 is a donor group of formula (Xa), (Xb), or (Xd) and R 5 and R 7 are H; or

R 5 is a donor group of formula (Xa), (Xb), or (Xd) and R 3 and R 7 are H; or R ula (Xa), (Xb), or (Xd) and R 5 is H; or

(la'"), wherein

R 3 and R 5 are H and R 7 is a donor group of formula (Xa), (Xb), or (Xd); or

R 3 is a donor group of formula (Xa), (Xb), or (Xd) and R 5 and R 7 are H; or

R 5 is a donor group of formula (Xa), (Xb), or (Xd) and R 3 and R 7 are H; or R 3 and R 7 are a donor group of formula (Xa), (Xb), or (Xd) and R 5 is H; and

X i and X 2 are independently of each other O, S, N(R i s), or C(R 6 )(R 17 );

R 8 and R 9 are H, or

R 8 and R 9 together form a group of formula R 10 , R 11 , R 12 , R 21 and R 21 ' C 2 5alkyl group;

R 15 is a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group.

Most preferred are compound of formula (la"), wherein

is H and R 7 is a donor group of formula (Xa),

R 3 is a donor group of formula (Xa), (Xb), or (Xd) and R 7 is H; or

R 3 and R 7 are a donor group of formula (Xa), (Xb), or (Xd); or

a compound of formula (la'"), wherein

R 3 is H and R 7 is a donor group of formula (Xa), (Xb), or (Xd); or

R 3 is a donor group of formula (Xa), (Xb), or (Xd) and R 7 is H; or

R 3 and R 7 are a donor group of formula (Xa), (Xb), or (Xd) and

X i and X 2 are independently of each other O, S, N(R i s), or C(R 6 )(R 17 );

R 10 , R 11 , R 12 , R 21 and R 21 ' C 2 5alkyl group;

R 15 is a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group. In anot ent invention is directed to compounds of formula

, wherein

group of formula

R 7 and R 8 (Xb),

or (Xd); or

a compound of formula (lb), wherein

R 5 is a donor group of formula (Xa), (Xb), or (Xd), and

R 7 and R 8 are are independently of each other H, or a Ci-C25alkyl group; and

X i and X 2 are independently of each other O, S, N(R i s), or C(R 6 )(R 17 );

R 10 , R 11 , R 12 , R 21 and R 21 ' C 2 5alkyl group;

R 15 is a group of formula , or

R 16 and R 17 are independently of each other H, a Ci-C2salkyl group;

R 22 and R 23 are independently of each other H, or a Ci-C2salkyl group.

I diment the present invention is directed to compounds of formula

(lc), wherein R 1 (Xb),

or (Xd); and

Xi and X 2 are independently of each other O, S, (R i s), or C(R 16 )(R 17 );

R 8 and R 9 are H, or

R 8 and R 9 together form a

Rio RII _ R12 R21 anc | R21' C 2 salkyl group;

R 15 is a group of formula , or

R 16 and R 17 are independently of each other H, or a Ci-C25alkyl group;

R22 and R 23 are independently of each other H, or a Ci-C25alkyl group.

Examples of donor groups of formula (Xa) are a group of formula

and

e preferred. Groups of formula

and are most preferred.

Examples of the donor group of formula (Xb) are groups of formula

mong the donor groups of formula (Xd) a group of fomula is prefferred. The donor gro bly a donor group of formula (Xa), wherein X 1 is O, S,

C(CH3)(CH3), ; or a donor group of formula (Xb), wherein X 2 is a single bond and R 12 is H; or a donor group of formula (Xd), wherein R 21 and R 21' are H. Among the donor groups of formula (Xa), (Xb) and (Xd) donor groups of formula (Xa) and (Xc) are preferred. Donor groups of formula (Xa) are most preferred.

A

are most preferred.

The above compounds of formula (I) may used as host, or guest in the emitting layer of organic light emitting elements.

Accordingly, the present invention is also directed to a light-emitting layer and an organic light emitting element comprising the above compounds of formula (I). The light-emitting layer comprises a light-emitting layer comprises

i) a compound of formula (I) as guest and a host material; or

ii) a compound of formula (I) as host and a fluorescent guest material.

The organic light-emitting element comprises a light-emitting layer comprising

i) a compound of formula (I) as guest and a host material; or

ii) a compound of formula (I) as host and a fluorescent guest material. The organic light- emitting element is characterized in that it emits delayed fluorescence and is described in more detail above.

The above compounds of formula (I) can be used in electrophotographic photoreceptors, photoelectric converters, sensors, dye lasers, solar cell devices and organic light emitting elements.

The benzotriazoles of the present invention can be synthesized using copper catalyzed Ullmann conditions or palladium catalyzed Buchwald-Hartwig conditions. Suitable benzotri- azole base skeletons are either commercially available, or can be obtained by processes known to those skilled in the art. Reference is made to WO2005/054212. The following examples are included for illustrative purposes only and do not limit the scope of the claims. Unless otherwise stated, all parts and percentages are by weight.

Examples

a) Phenyl hydrazine HCI (0.39 mol) and NaOAc.3H 2 0 (0.59 mol) are placed in a 1.5 I flask with EtOH 550 ml. While stirring, 1-fluoro-4-bromo-2-nitrobenzene (0.20 mol) is added (by pouring). The slurry becomes slightly orange. The mixture is heated to reflux overnight (20 hours). After cooling to room temperature, the mixture is filtered and washed with EtOH. Without vacuum on the frit, water is added with stirring to dissolve the NaCI and NaF. Vacuum is applied and the process is repeated. Stirring twice with MeOH in the same manner and applying vacuum give a light orange solid. Volatiles are removed in vacuum. (Yield:

b) The product from example 1a (0.11 mol), and sodium hydrogen sulfite (0.11 mol) are placed in a 250 ml 3 neck round balloon with 200 ml dimethyl formamide (DMF). While stirring, the reaction mixture is heated to 110 °C overnight. After cooling to room temperature, the mixture is poured into 300 ml ice water, and then the precipitate is filtered off and washed with 1000 ml water and 500 ml EtOH. Volatiles are removed in vacuum give a slightly beige powder (yield: 35.5 %). 1 H-NMR (ppm, CDCb): 8.15 (dd, 2H), 8.03 (d, 1 H), 7

c) The product from example 1 b (1.45 mmo), phenoxazine (1.75 mmol), palladium acetate (0.03 mmol), tri-tert-Buthylphosphine (0.06 mmol), sodium t-buthoxide (2.9 mmol) and 10 ml of toluene are placed in a 50 ml flask. The mixture is stirred at 1 10°C overnight and cooled. The mixture is then poured into H2O and extracted with ethylacetate. The organic layer is dried over MgS04 and concentrated by evaporation. Column chromatography of the crude product with dichloromethane / hexane (1 :15-1 :5) as eluent gives a yellow solid (yield: 81.9%). The product is subsequently purified using zone sublimation. 1 H-NMR (ppm, CDCb): 8.33 (td, 3H), 8.24 (d, 1 H), 7.69 (td, 2H), 7.60 (td, 1 H), 7.45 (dd, 1 H), 6.76 (dd, 2H), 6.72-6.61 (m, 4H), 5.97 (dd, 2H).

Example 2

a) 4-Bromoaniline (58.14 mmol) is dissolved in 200 ml water using 174 mmol HCI. The mixture is cooled to 0°C and sodium nitrite (58.1 mmol) in 30 ml water is added dropwise over 30 minutes. After 45 minutes the diazonium salt is added via cannula to a mixture of 1- amino-4-bromonaphthalene (58.14 mmol) in 300 ml ethanol at 0°C. After 2 hours sodium carbonate (80.2 mmol) in 100 ml water is added dropwise, producing a pH of 7. After an additional 30 minutes the red precipitate is filtered and washed with water (2 x 300 ml). The brown-red solid is triturated in 100 ml methanol overnight, filtered and dried. The product is dried in vacuo to give a bright red solid (yield: 91.0%). 1 H-NMR (ppm, (CDs^SO): 8.59 ( (d, 1 H), 8.04 (d, 2H), 7.82 (d, 1 H), 7.76 (d, 2H), 7.70 (t, 1 H).

b) The product from step 2a (49.37 mmol) and copper(ll) acetate (0.49 mmol) are placed in a 250 ml flask with a stir bar. 250 ml tert-amyl alcohol is added and the mixture is heated to 80°C. tert-Butyl hydroperoxide, (98.7 mmol) is slowly added and the reaction is monitored by TLC. The flask is cooled to room temperature and the product is filtered. Washing with tert- amyl alcohol and removal of volatiles in vacuo give a light brown solid. The product is triturated in 30 ml methanol overnight, filtered and dried to give an off-white solid (yield: 77.0%). 1 H-NMR (ppm, CDCb): 8.47 (m, 1 H), 8.20 (d, 1 H), 8.08 (d, 2H), 8.01 (s, 1 H), 7.58 (

c) The product from example 2b (2.40 mmo), phenoxazine (6.2 mmol), palladium acetate (0.01 mmol), tri-tert-buthylphosphine (0.02 mmol), sodium t-buthoxide (7.2 mmol) and 30 ml of toluene are placed in a 100 ml flask. The mixture is stirred at 110°C overnight and cooled. The mixture is then poured into H2O and extracted with ethylacetate. The organic layer is dried over MgSCu and concentrated by evaporation. Column chromatography of the crude product with ethylacetate / hexane (1 :5) as eluent, followed by reprecipitation from dichloromethane-hexane gives a yellow solid (yield: 53.0%). The product is subsequently purified using zone sublimation. 1 H-NMR (ppm, CDCb): 8.73 (d, 1 H), 8.61 (d, 2H), 8.35 (s, 1 H), 8.06 (d, 1 H), 7.75 (m, 3H), 6.82-6.65 (m, 11 H), 6.57 (td, 2H), 6.03 (m, 2H), 5.90 (dd,

2H).

4-Bromophenyl hydrazine-HCI (0.39 mol), and NaOAc.3H20 (0.59 mol) are placed in a 1.5 I flask with EtOH 550 ml. While stirring, 1-fluoro-4-bromo-2-nitrobenzene (0.20 mol) is added (by pouring). The slurry becomes slightly orange. The mixture is heated to reflux overnight (20 hours). After cooling to room temperature, the mixture is filtered and washed with EtOH. Without vacuum on the frit, water is added with stirring to dissolve the NaCI and NaF. Vacuum is applied and the process is repeated. Stirring twice with MeOH in the same manner and applying vacuum give a light yellow, crystalline solid. Volatiles are removed in

b) The product from example 3a (0.11 mol), and sodium hydrogen sulfite (0.11 mol) are placed in a 250 ml 3 neck round balloon with 200 ml DMF. While stirring, the reaction mixture is heated to 1 10 °C overnight. After cooling to room temperature, the mixture is poured into 300 ml ice water, and then the precipitate is filtered off and washed with 1000 ml water and 500 ml EtOH. Volatiles are removed in vacuum give a slightly beige powder (yield: 93.4 %). 1 H-NMR (ppm, CDC ): 8.21 (dd, 2H), 8.09 (d, 1 H), 7.79 (dd, 1 H), 7.67 (dd, 2H), 7.49 (

c) The product from example 3b (0.62 mmo), phenoxazine (1.55 mmol), palladium acetate (0.01 mmol), tri-tert-buthylphosphine (0.02 mmol), sodium t-buthoxide (1.87 mmol) and 10 ml of toluene are placed in a 50 ml flask. The mixture is stirred at 1 10°C overnight and cooled. The mixture is then poured into H2O and extracted with ethylacetate. The organic layer is dried over MgS04 and concentrated by evaporation. Column chromatography of the crude product with dichloromethane / hexane (1 :10) as eluent gives a yellow solid

(yield: 30.6%). The product is subsequently purified using zone sublimation. 1 H-NMR (ppm, CDCI3): 8.60 (d, 2H), 8.35 (d, 1 H), 8.29 (d, 1 H), 7.75 (d, 2H), 7.49 (dd, 1 H), 6.80-6.63 (m, 12H), 6.00 (dd, 4H)

Appplication Example 1

a) Photoluminescent characterization in neat film

On a silicon substrate, compound (A-5) is vacuum- deposited in a thickness of 50 nm. Absorption, fluorescent spectra (excitation at 339nm) and photoelectron yield spectroscopy of the film are measured, subsequently HOMO and LUMO (eV) of the compound are estimated as 5.76eV and 3.20eV, respectively. b) Photoluminescent characterization in host-guest film

On a silicon substrate, mCBP doped with 8.6 % by weight of compound (A-5) is co- deposited in a thickness of 100 nm. The time-resolved and temperature-dependent emission spectra of the host-guest film are measured by photoluminescence spectroscopy with a streak camera. The prompt ( ~ 30ns) and delayed (>1 S) fluorescent components and the temperature dependency are observed as shown in Fig. 1 and Table 1. The host-guest film shows an emission peak at 520 nm in PL spectrum (see Fig. 2).

Table 1. Temperature dependency of PL emission of codeposited film (mCBP doped with 8.6 % by weight of compound (A-5)) (streak camera)

These results indicate that compound (A-5) is a TADF material.

Application Example 2

An organic light emitting device (OLED) is fabricated by vacuum deposition of ITO (100nm)/ xaline-2,3,6,7,10,11-hexacarbonitrile (HAT-CN) (10nm)/

(Tris-PCz, 30nm)/ 88.7 % by weight 3,3-di(9H-carbazol-9- yl)biphenyl (mCBP):11 2,4,6-tris(biphenyl-3-yl)-1 ,3,5-

triazine (T2T, 10nm)/ (Bpy-TP2, 40nm)/ LiF

(0.8nm)/ Al (100nm) on a glass substrate, subsequently the device is encapsulated and the performance of the device is evaluated. The device shows an emission peak at 534 nm in electroluminescence (EL) spectrum (see Fig. 2) with an external quantum efficiency (EQE) of 11.1 % which is higher than the theoretical value of conventional fluorescent materials (EQE = 5-7.5%).

Application Example 3

Application Example 2 is repeated except that compound (A-5) is replaced by compound (A-6) and the emitting layer consists of 90.7 % by weight of mCBP and 9.3 % by weight of compound (A-6).

Application Example 4

An organic light emitting device (OLED) is fabricated by vacuum deposition of ITO (100nm)/ N-[4-[4-[N-(1-naphthyl)anilino]phenyl]phenyl]-N-phenyl-napht halen-1-amine (a-NPD, 30nm) / 4-carbazol-9-yl-N,N-bis(4-carbazol-9-ylphenyl)aniline (TCTA, 20nm)/ [9-(4-tert- butylphenyl)-6-triphenylsilyl-carbazol-3-yl]-triphenyl-silan e (CzSi, 10nm) / 82 % by weight of -(diphenylphosphino)phenyl)ether oxide (DPEPO): 18 % by weight of compound

(A-7) (20nm) / DPEPO (10nm)/ 2-[3,5-bis(1- phenylbenzimidazol-2-yl)phenyl]-1-phenyl-benzimidazole (TPBi, 30nm)/ LiF (0.8nm)/ Al (100nm) on a glass substrate, subsequently the device is encapsulated and the performance of the device is evaluated.

Application Example 5

Application Example 2 is repeated except that compound A-5 is replaced by compound

(A-8) and the emitting layer consists of 87 % by weight of mCBP and 13 % by weight of compound (A-8). Application Example 6

except that compound A-5 is replaced by compound

(A-9) and the emitting layer consists of 88 % by weight mCBP and 12 % by weight of compound (A-9).

Table 2 - EL performance of the devices of Application Examples 3 to 6

The devices of Application Examples 3 to 6 show emission peaks at 516 to 569 nm in EL spectrum with EQEs of 7.6 to 15.7 %, which are higher than the theoretical value of conventional fluorescent materials (EQE = 5-7.5%).